Phospholipase-C gamma-1 (PLCγ-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells

被引:13
作者
Davies, Gaynor [1 ]
Martin, Tracey A. [1 ]
Ye, Lin [1 ]
Lewis-Russell, Jonathon A. [1 ]
Mason, Malcolm D. [2 ]
Jiang, Wen G. [1 ]
机构
[1] Cardiff Univ, Sch Med, Dept Surg, Metastasis & Angiogenesis Res Grp, Cardiff, S Glam, Wales
[2] Velindre Hosp, Cardiff & Vale NHS Trust, Sect Clin Oncol, Dept Med, Cardiff, S Glam, Wales
关键词
ribozyme; HGF/SF; PLC gamma-1; prostate cancer; migration; invasion;
D O I
10.1016/j.urolonc.2007.06.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Phospholipase C gamma-1 (PLC gamma-1) is an intracellular signalling molecule regulating a number of biological processes including transporter mechanisms, transcription factors, and scaffolding proteins mediating cytoskeleton and membrane trafficking. Hepatocyte growth factor (HGF) is a pleiotrophic factor and a mediator of metastatic spread. This study sought to determine the effect of HGF on the invasive and migratory potential of prostate cancer cells targeted by a ribozyme transgene to PLC gamma-1. Methods: A ribozyme transgene consisting of hammerhead ribozyme and antisense specific to PLC gamma-1 was cloned into a PEF6 expression vector and transfected into PC-3 cells. RT-PCR and Western blotting confirmed knock down of PLC gamma-1. In vitro invasion and a cytodex-2 bead motility assays with in vitro and in vivo growth models were used to assess the impact of PLC gamma-1 manipulation. Results: PC-3 cells stably transfected with PLC gamma-1 ribozyme transgene (PC-3(Delta PLC)gamma) manifested a reduction of PLC gamma-1 expression at mRNA/protein levels. HGF/SF increased invasiveness (P < 0.01) and motility (P < 0.0001) of PC-3(WT) and PC-3(PEF6) cells. In contrast, PLC gamma-1 knock down PC-3(Delta PLC)gamma cells had reduced invasiveness (P < 0.05) and motility (P < 0.01) compared with PC-3(WT) and PC-3(PEF6) cells. Although there was a marginal change of cell growth in vitro, there was no difference in the rate of growth between PC-3(Delta PLC)gamma, PC-3(WT), and PC-3(PEF6) cells. Conclusion: Targeting PLC gamma-1 by way of a hammerhead ribozyme to PLC gamma-1 is an effective method in reducing invasive phenotype of prostate cancer. PLC gamma-1 is a signalling intermediate that has prime influence on HGF induced cellular invasion and migration without affecting the growth of the cells. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:386 / 391
页数:6
相关论文
共 25 条
[1]   Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression [J].
Abounader, R ;
Ranganathan, S ;
Lal, B ;
Fielding, K ;
Book, A ;
Dietz, H ;
Burger, P ;
Laterra, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (18) :1548-1556
[2]   INOSITOL PHOSPHATES AND CELL SIGNALING [J].
BERRIDGE, MJ ;
IRVINE, RF .
NATURE, 1989, 341 (6239) :197-205
[3]  
Carraway RE, 2004, J PHARMACOL EXP THER, V309, P439
[4]   Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells [J].
Carraway, RE ;
Gui, XY ;
Cochrane, DE .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (02) :640-650
[5]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[6]  
Davies G, 2001, CLIN CANCER RES, V7, P3289
[7]   Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells [J].
Davies, G ;
Watkins, G ;
Mason, MD ;
Jiang, WG .
PROSTATE, 2004, 60 (04) :317-324
[8]  
Faletto D L, 1993, EXS, V65, P107
[9]   Sustained recruitment of phospholipase C-γ to Gab1 is required for HGF-induced branching tubulogenesis [J].
Gual, P ;
Giordano, S ;
Williams, TA ;
Rocchi, S ;
Van Obberghen, E ;
Comoglio, PM .
ONCOGENE, 2000, 19 (12) :1509-1518
[10]   Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-β connection [J].
Jiang, WG ;
Davies, G ;
Fodstad, O .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 330 (01) :253-262